Category

Corporate News

American Thyroid Association

American Thyroid Association Statement on Desiccated Thyroid Extract

By | Corporate News, Featured, Friends of the ATA, News Releases, Public Health Statements

Hypothyroidism is a common endocrine problem affecting mostly women. If untreated, it leads to impaired quality of life and function. The standard therapy for hypothyroidism, as recommended by the American Thyroid Association® (ATA), is synthetic levothyroxine, a safe and effective therapy. The US Food and Drug Administration (FDA) regulates levothyroxine medications to ensure bioavailability, dose equivalence, potency, and purity.

Read More
Editorial Collaboration ATA and Medscape

Medscape & ATA Podcast Collaboration Presents: Molecular Marker Testing for Evaluation of Thyroid Nodules

By | Corporate News, Featured, Friends of the ATA, Thyroid Nodules

Over the past decade, molecular diagnostics have transformed how we assess cancer risks, help avoid unnecessary surgeries, and make personalized treatment decisions. In this episode, we’ll discuss the evolution of the molecular testing, review commonly used platforms, and explore how to apply the results effectively in clinical practice.

Read More